Bloomsbury Genetic Therapies launches with Seed financing of £5 million to develop potentially curative gene therapy treatments for rare neurological

Bloomsbury Genetic Therapies launches with Seed financing of £5 million to develop potentially curative gene therapy treatments for rare neurological and metabolic diseasesLondon, UK, 7 October 2022 – Bloomsbury Genetic Therapies Limited (“Bloomsbury”), a  biotechnology company developin...

Related Keywords

United Kingdom ,London ,City Of ,Merck Serono ,Oxford Glycosciences ,John Ilett ,Simon Waddington ,Leigh Shaw ,Leigh Brody ,Manju Kurian ,Ahad Rahim ,Frank Armstrong ,Gensight Biologics ,Adrien Lemoine ,Michael Diem ,Paul Gissen ,Andrea Spezzi ,Amicus Therapeutics ,Research Professor ,Cell Gene Therapy Therapeutic Innovation Network ,Animal Health Group ,Biomedical Research Council ,Bloomsbury Genetic Therapies Limited ,Venatorx Pharmaceuticals ,Astrazeneca ,Rejuvitas Inc ,Technology Fund ,Wellcome ,Head Of Research Department Pharmacology ,Institute Of Child Health ,Faron Pharmaceuticals ,Head Of Regulatory Affairs ,Bloomsbury Genetic Therapies ,Ornithine Transcarbamylase Deficiency ,Dopamine Transporter Deficiency Syndrome ,Infantile Neuroaxonal Dystrophy ,Chief Executive Officer ,Investment Manager ,Paediatric Metabolic Diseases ,Honorary Consultant ,Great Ormond Street Hospital ,Niemann Pick ,United Kingdom Chief Investigator ,Molecular Neurosciences ,Ormond Street Institute ,Child Health ,Paediatric Neurology ,Accelerating Novel Therapies ,Research Council ,Translational Neuroscience ,Research Department ,Wellcome Chair ,Gene Therapy ,Gene Therapy Therapeutic Innovation ,Professors Gissen ,Orchard Therapeutics ,Chief Business ,Chief Operating Officer ,Chief Legal ,Chief Legal Officer ,Senior Vice President ,Regulatory Affairs ,Nightstar Therapeutics ,United Neuroscience ,Marketing Authorisation Application ,Independent Directors ,Chief Executive ,Fulcrum Pharma ,Non Executive Director ,Newcells Biotech ,Health Group ,Senior Advisory Board ,Healthcare Royalty ,Chief Business Officer ,Principal Finance Officer ,Aevi Genomic Medicine ,Board Director ,Chief Medical Officer ,